Viewing Study NCT00677612


Ignite Creation Date: 2025-12-26 @ 10:20 PM
Ignite Modification Date: 2026-02-28 @ 5:28 AM
Study NCT ID: NCT00677612
Status: TERMINATED
Last Update Posted: 2009-12-29
First Post: 2008-05-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer
Sponsor:
Organization:

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Phases:

Phases

Phase Brief Phase Text View
None PHASE1 View
None PHASE2 View
Observational Models:
Time Perspective List:
Who Masked List: